FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ludovic Ferrer

Research Profile

Procedures

Chemicals & Drugs

Devices

Concepts & Ideas

Disorders

Objects

Co-author Network

Publications

TOP 3
Caroline Rousseau; Stéphane Supiot; John Wijdenes; Jacques Barbet; Manuel Bardiès; Pierre Baumgartner; François Davodeau; Alain Faivre-Chauvet; Ludovic Ferrer; Thierry Guillaume; Jean-Luc Harousseau; Françoise Kraeber-Bodéré; Marie Lacombe; Philippe Moreau; Michel Cherel
Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients.
Caroline Rousseau; Anne Devillers; Mario Campone; Loïc Campion; Ludovic Ferrer; Christine Sagan; Myriam Ricaud; Boumédiène Bridji; Françoise Kraeber-Bodéré
FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients.
Ludovic Ferrer; Françoise Kraeber-Bodéré; Caroline Bodet-Milin; Caroline Rousseau; Stephen Le Gouill; William A Wegener; David M Goldenberg; Manuel Bardiès
Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ludovic Ferrer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Caroline Rousseau; Stéphane Supiot; John Wijdenes; Jacques Barbet; Manuel Bardiès; Pierre Baumgartner; François Davodeau; Alain Faivre-Chauvet; Ludovic Ferrer; Thierry Guillaume; Jean-Luc Harousseau; Françoise Kraeber-Bodéré; Marie Lacombe; Philippe Moreau; Michel Cherel
Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012;33(3):679-88.
2011: Caroline Rousseau; Anne Devillers; Mario Campone; Loïc Campion; Ludovic Ferrer; Christine Sagan; Myriam Ricaud; Boumédiène Bridji; Françoise Kraeber-Bodéré
FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients.
European journal of nuclear medicine and molecular imaging 2011;38(6):1029-36.
2010: Ludovic Ferrer; Françoise Kraeber-Bodéré; Caroline Bodet-Milin; Caroline Rousseau; Stephen Le Gouill; William A Wegener; David M Goldenberg; Manuel Bardiès
Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy.
Cancer 2010;116(4 Suppl):1093-100.
2009: Helena Uusijärvi; Nicolas Chouin; Peter Bernhardt; Ludovic Ferrer; Manuel Bardiès; Eva Forssell-Aronsson
Comparison of electron dose-point kernels in water generated by the Monte Carlo codes, PENELOPE, GEANT4, MCNPX, and ETRAN.
Cancer biotherapy & radiopharmaceuticals 2009;24(4):461-7.
2007: Ludovic Ferrer; Nicolas Chouin; Abdalkader Bitar; Albert Lisbona; Manuel Bardiès
Implementing dosimetry in GATE: dose-point kernel validation with GEANT4 4.8.1.
Cancer biotherapy & radiopharmaceuticals 2007;22(1):125-9.
2006: Caroline Rousseau; Anne Devillers; Christine Sagan; Ludovic Ferrer; Boumédiène Bridji; Loïc Campion; Myriam Ricaud; Emmanuelle Bourbouloux; Isabelle Doutriaux; Martine Clouet; Dominique Berton-Rigaud; Catherine Bouriel; Valérie Delecroix; Etienne Garin; Sophie Rouquette; Isabelle Resche; Pierre Kerbrat; Jean-François Chatal; Mario Campone
Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(34):5366-72.
2006: Françoise Kraeber-Bodéré; Caroline Rousseau; Caroline Bodet-Milin; Ludovic Ferrer; Alain Faivre-Chauvet; Loïc Campion; Jean-Philippe Vuillez; Anne Devillers; Chien-Hsing Chang; David M Goldenberg; Jean-François Chatal; Jacques Barbet
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(2):247-55.
2005: Jean-Marc Classe; Maryse Fiche; Caroline Rousseau; Christine Sagan; François Dravet; Raphaëlle Pioud; Albert Lisbona; Ludovic Ferrer; Loïc Campion; Isabelle Resche; Chantal Curtet
Prospective comparison of 3 gamma-probes for sentinel lymph node detection in 200 breast cancer patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(3):395-9.
2005: Damien Autret; Abdalkader Bitar; Ludovic Ferrer; Albert Lisbona; Manuel Bardiès
Monte Carlo modeling of gamma cameras for I-131 imaging in targeted radiotherapy.
Cancer biotherapy & radiopharmaceuticals 2005;20(1):77-84.
2005: Eric Mirallié; Jean-Philippe Vuillez; Stéphane Bardet; Eric Frampas; B Dupas; Ludovic Ferrer; Alain Faivre-Chauvet; Arnaud Murat; Bernard Charbonnel; Jacques Barbet; David M Goldenberg; Jean-François Chatal; Françoise Kraeber-Bodéré
High frequency of bone/bone marrow involvement in advanced medullary thyroid cancer.
The Journal of clinical endocrinology and metabolism 2005;90(2):779-88.
2003: Françoise Kraeber-Bodéré; Alain Faivre-Chauvet; Ludovic Ferrer; Jean-Philippe Vuillez; Pierre-Yves Brard; Caroline Rousseau; Isabelle Resche; Anne Devillers; Sophie Laffont; Manuel Bardiès; Ken Chang; Robert M Sharkey; David M Goldenberg; Jean-François Chatal; Jacques Barbet
Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3973S-81S.
2003: Grégory Delpon; Ludovic Ferrer; Albert Lisbona; Manuel Bardiès
Impact of scatter and attenuation corrections for iodine-131 two-dimensional quantitative imaging in patients.
Cancer biotherapy & radiopharmaceuticals 2003;18(2):191-9.
2003: Isabelle Gardin; Lionel Gerard Bouchet; Karine Assié; Jerome Caron; Albert Lisbona; Ludovic Ferrer; Wesley E Bolch; Pierre Vera
Voxeldoes: a computer program for 3-D dose calculation in therapeutic nuclear medicine.
Cancer biotherapy & radiopharmaceuticals 2003;18(1):109-15.
2003: Ludovic Ferrer; Grégory Delpon; Albert Lisbona; Manuel Bardiès
Dosimetric impact of correcting count losses due to deadtime in clinical radioimmunotherapy trials involving iodine-131 scintigraphy.
Cancer biotherapy & radiopharmaceuticals 2003;18(1):117-24.
2002: Grégory Delpon; Ludovic Ferrer; Albert Lisbona; Manuel Bardiès
Correction of count losses due to deadtime on a DST-XLi (SmVi-GE) camera during dosimetric studies in patients injected with iodine-131.
Physics in medicine and biology 2002;47(7):N79-90.
2002: Grégory Delpon; Ludovic Ferrer; Corinne Lenta; Albert Lisbona; Iréne Buvat; Manuel Bardiès
Comparison of four scatter correction methods for patient whole-body imaging during therapeutic trials with iodine-131.
Cancer 2002;94(4 Suppl):1224-30.
1999: Françoise Kraeber-Bodéré; Stéphane Bardet; Cornelis A Hoefnagel; M R Vieira; Jean-Philippe Vuillez; Arnaud Murat; T C Ferreira; Manuel Bardiès; Ludovic Ferrer; Isabelle Resche; E Gautherot; E Rouvier; Jacques Barbet; Jean-François Chatal
Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3190s-3198s.